trending Market Intelligence /marketintelligence/en/news-insights/trending/bm2kTC4Ts7YH7nRhpXvJbw2 content esgSubNav
In This List

Misonix closes $109M all-stock deal for wound care company Solsys Medical

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Misonix closes $109M all-stock deal for wound care company Solsys Medical

Medical device maker Misonix Inc. closed its acquisition of Virginia-based Solsys Medical LLC in an all-stock transaction valued about $109 million.

New York-based Misonix acquired Solsys by issuing about 5.7 million new shares to former unitholders of the wound care company. Also, Misonix assumed Solsys' outstanding secured debt of about $24 million.

Misonix shareholders now own about 64% of the combined entity, and former Solsys unitholders own the remaining 36%.

The deal adds Solsys' wound treatment TheraSkin to Misonix's product portfolio, which includes wound debridement solution SonicOne.